A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

NCT01870739 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: sacubitril/valsartan (LCZ696)
DRUG: olmesartan
OTHER: placebo to sacubitril/valsartan (LCZ696)
OTHER: placebo to olmesartan
DRUG: Amlodipine (Optional)

Sponsor

Novartis Pharmaceuticals